identification and analysis of antisense rna target regions of the human immunodeficiency virus type 1.

NLM AIDSLINE Identification and analysis of antisense RNA target regions of the human immunodeficiency virus type 1. Rittner K; Sczakiel G; Institut fur Virusforschung, Deutsches
August 30, 1991

Nucleic Acids Res. 1991 Apr 11;19(7):1421-6. Unique Identifier : Antisense RNA, transcribed intracellularly from constitutive expression cassettes, inhibits the replication of the human immunodeficiency virus type 1 (HIV-1) as demonstrated by a quantitative microinjection assay in human SW480 cells. Infectious proviral HIV-1 DNA was co-microinjected together with a fivefold molar excess of plasmids expressing antisense RNA complementary to a set of ten different HIV-1 target regions. The most inhibitory antisense RNA expression plasmids were targeted against a 1 kb region within the gag open reading frame and against a 562 base region containing the coding sequences for the regulatory viral proteins tat and rev. Experimental evidence is presented that the antisense principle is the inhibitory mechanism in this assay system. Cell Line Cloning, Molecular Human HIV Antigens/ANALYSIS HIV-1/GENETICS/PHYSIOLOGY Microinjections Plasmids RNA, Antisense/GENETICS RNA, Viral/*GENETICS Substrate Specificity Support, Non-U.S. Gov't Virus Replication JOURNAL ARTICLE

Most Read: Latest Added Related Topics White House LGBT Conference on HIV/AIDS UNITED STATES: White House in Atlanta: LGBT AIDS Conference No more single-theme conferences: global HIV prevention conference planned FHI 360 Senior Scientist Lut Van Damme Receives International Microbicide Conference Lifetime Achievement Award Equatorial Guinea Ministry of Health and Social Welfare and UNICEF Refute Erroneous AIDS Prevalence Figures Photographs from A Day with HIV Now Online Bulgaria urges Libya to investigate AIDS nurses case Engineers enter fight against AIDS in Africa Gilead’s Complera® Non-Inferior to Atripla® Among Treatment-Naive HIV Patients UN chief Ban calls world leaders to end Aids by 2020 Fight Breast Cancer and More at Walk The World, A First of Its Kind Walkathon at The Walt Disney World Resort in Florida When it comes to deadly viruses, what's in a name?Policy change has yet to affect HIV-positive sailors Immune system cancer drugs tipped to be a $35 billion market Accidental find shows Vitamin C kills tuberculosis Study Finds Vitamin C Can Kill Drug-Resistant TB Big jump in HIV among Navajo in New Mexico Peace Corps to accept same-sex couples UNAIDS reports more than 7 million people now on HIV treatment across Africa––with nearly 1 million added in the last year - while new HIV infections and deaths from AIDS continue to fall COLORADO: Boulder Groups Honor More Than 150 Local AIDS Victims When it comes to deadly viruses, what's in a name?General Secretariat of the League of Arab States and UNAIDS to work toward an accelerated HIV response in the Arab Region CANADA: Nunavut Undertakes Hepatitis Survey in Baffin, Kivalliq Regions 2012 US medicine sales show shifts by drug type Analysis: Sending the right message on mHealth Analysis: The plight of LGBTI asylum seekers, refugees Study Results from Eunice Kennedy Shriver National Institute of Child Health and Human Development Provide New Insights into HIV/AIDS Monetising Human Waste and 101 (Slightly) Crazy Other Ideas Mpumalanga district falling behind NSP targets Inhibikase Therapeutics to present at 5th International Congress on Polyomaviruses and Human Diseases - May 11, 2013 Grand Hotel Bristol, Stresa, Italy
Information in this article was accurate in August 30, 1991. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.